2013;61:1183 91. S7.9.1.5-6. Giustetto C, Di MF, Wolpert C, et al. Short QT syndrome: clini- cal findings and diagnostic-therapeutic implications. Eur Heart J. 2006;27:2440 7. S7.9.1.5-7. Bun SS, Maury P, Giustetto C, et al. Electrical storm in short-QT syndrome successfully treated with isoproterenol. J Cardiovasc Electrophysiol. 2012;23:1028 30. S7.9.1.5-8. Guerrier K, Kwiatkowski D, Czosek RJ, et al. Short QT interval prevalence and clinical outcomes in a pediatric population. Circ Arrhythm Electrophysiol. 2015;8:1460 4. S7.9.1.5-9. Iribarren C, Round AD, Peng JA, et al. Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Ann Noninvasive Electrocardiol. 2014;19:490 500. S7.9.1.5-10. Gollob MH, Blier L, Brugada R, et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited car- diac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint posi- tion paper. Can J Cardiol. 2011;27:232 458. CLINICAL STATEMENTS AND GUIDELINES 8. VA IN THE STRUCTURALLY NORMAL HEART S8-1. Gill JS, Blaszyk K, Ward DE, et al. Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. Am Heart J. 1993;126:1126 33. S8-2. Gill JS, Ward DE, Camm AJ, Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia. Pacing Clin Electrophysiol. 1992;15:2122 6. S8-3. Kontos MC, Diercks DB, Ho PM, et al. Treatment and outcomes in patients with myocardial infarction treated with acute beta blocker therapy: results from the American College of Cardiology s NCDR(R). Am Heart J. 2011;161:864 70. S8-4. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amioda- rone for recurrent sustained hypotensive ventricular tachyarrhyth- mias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol. 1996;27:67 75. S8-5. Noda T, Shimizu W, Taguchi A, et al. 